Track how companies discuss tariffs and trade policies in their earnings calls, and understand their impact across different industries and regions.
The somewhat pause that we're seeing from larger organizations and medium-sized organizations due to the tariff concerns last all through the quarter.
We do not yet see any decrease in the appetite of our non-US clients for opening an account and trading mostly US markets.
We're monitoring markets, tariff policy, tax rules, regulatory requirements, and we'll react as necessary to steer our company.
Our credit officers are working their portfolios, trying to understand what tariffs or a protracted trade war could do to our portfolio.
clients are simply waiting on more clarity on trade policy and the regulatory environment before committing to deals.
What's included in the $400 million, and again, that is primarily MedTech tariffs at this point.
the prospect of a recession has increased with growing indications that economic activity is slowing down around the world. This uncertainty around the path forward and fears over the potentially escalating effects of the trade war have created material risks to the US and global economy.
The ultimate impact on tariffs on the broader economy remains unknown at this point.
Importantly, our construction remains on schedule for our first building and we expect it to be ready for service and ready to begin generating revenue in the calendar fourth quarter of 2025. Nearly all the equipment for this building is landed, giving us not only confidence in the schedule, but it also means tariffs will not materially impact our build cost.
the main thing that we see there is what would appear to be a certain amount of front-loading of spending ahead of people expecting price increases from tariffs.